Tandem Diabetes Care, Inc. TNDM shares soared 7.6% in the last trading session to close at $17.61. The move was backed by solid volume with far more shares changing hands than in a normal session.

Fintel reports that on April 10, 2025, Mizuho initiated coverage of Tandem Diabetes Care (NasdaqGM:TNDM) with a Neutral ...

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $35.11, a high ...

Global diabetes deaths and disability are rising, particularly in India, China, and the US, with type 2 diabetes (T2DM) ...

Mizuho initiated coverage of Tandem Diabetes (TNDM) with a Neutral rating and $20 price target The firm’s neutral stance reflects both the ...

The doctors say barriers continue to prevent access to AID, including costs. Such barriers exemplify “the implicit ...

Lake Street analyst Brooks O’Neil maintained a Buy rating on Tandem Diabetes Care (TNDM – Research Report) today and set a price target of ...

Abbott, Dexcom, Insulet, Medtronic and others are developing next-gen sensors, pumps and algorithms for type 2 diabetes ...

These stocks offer a middle ground with... Tandem Diabetes Care, Inc. (NASDAQ:TNDM) came out with quarterly earnings of $0.10 per share, beating the Zacks Consensus Estimate ...

People who might be considered thin or skinny can develop prediabetes, type 2, and gestational diabetes. Weight is one possible risk factor, including age, family medical history, and ethnicity.

Doctors use the A1C test to check for prediabetes and diabetes. A range of 5.7 to 6.4% suggests a person may have prediabetes. Over 6.5% indicates diabetes. This test also helps doctors monitor ...